Keyphrases
Randomized Placebo-controlled Trial
100%
Ischemia-reperfusion Injury
100%
Lung Transplantation
100%
Human Being
100%
Complement Inhibition
100%
Placebo Groups
50%
Cardiopulmonary Bypass
33%
Ventilation Rate
33%
Statistical Significance
16%
Placebo
16%
Clinical Trials
16%
Ventilator
16%
Complement Activation
16%
Infection Rate
16%
Ventilator-free Days
16%
Complement Receptors
16%
Length of Hospital Stay
16%
Operative
16%
Reperfusion
16%
Intensive Care Unit
16%
Large Reduction
16%
Placebo-controlled Trial
16%
Transplant Program
16%
Convertase
16%
Extubated
16%
Early Extubation
16%
Medicine and Dentistry
Placebo
100%
Reperfusion Injury
100%
Lung Transplantation
100%
Complement Inhibition
100%
Artificial Respiration
33%
Cardiopulmonary Bypass
33%
Infection
16%
Clinical Trial
16%
Intensive Care Unit
16%
Complement Activation
16%
Complement Component C3b Receptor
16%
Extubation
16%
Complement Component C5a
16%
Complement Component C3a
16%
Immunology and Microbiology
Lung Transplantation
100%
Reperfusion
100%
Complement Inhibition
100%
Homo sapiens
100%
Complement Activation
16%
Complement Receptor 1
16%
Complement Component 5a
16%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Reperfusion Injury
100%
Homo sapiens
100%
Infection
16%
Clinical Trial
16%
Complement Component C3b Receptor
16%
Complement Component C5a
16%
Complement Component C3a
16%